Novartis Aktie
100,20
EUR
+1,14
EUR
+1,15
%
93,26
CHF
+1,11
CHF
+1,20
%
Werbung
Novartis Aktie Analyse
31.03.20 | Novartis buy | Oddo BHF | |
24.03.20 | Novartis Underweight | JP Morgan Chase & Co. | |
20.03.20 | Novartis Hold | Deutsche Bank AG | |
17.03.20 | Novartis Underweight | Barclays Capital | |
11.03.20 | Novartis Equal-Weight | Morgan Stanley | |
26.02.20 | Novartis Hold | Deutsche Bank AG | |
25.02.20 | Novartis Underweight | Barclays Capital | |
25.02.20 | Novartis buy | Jefferies & Company Inc. | |
Werbung
|
|||
25.02.20 | Novartis Neutral | UBS AG | |
31.01.20 | Novartis Hold | Deutsche Bank AG | |
30.01.20 | Novartis Neutral | Credit Suisse Group | |
30.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
29.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
29.01.20 | Novartis Neutral | UBS AG | |
29.01.20 | Novartis Hold | Kepler Cheuvreux | |
29.01.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
20.01.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
16.01.20 | Novartis Underweight | Barclays Capital | |
16.01.20 | Novartis Neutral | Credit Suisse Group | |
09.01.20 | Novartis Hold | Deutsche Bank AG | |
06.01.20 | Novartis verkaufen | Morgan Stanley | |
06.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
17.12.19 | Novartis buy | Jefferies & Company Inc. | |
16.12.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
12.12.19 | Novartis Hold | Deutsche Bank AG | |
09.12.19 | Novartis Hold | Deutsche Bank AG | |
06.12.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
06.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
27.11.19 | Novartis Hold | HSBC | |
26.11.19 | Novartis Hold | HSBC | |
26.11.19 | Novartis Hold | Deutsche Bank AG | |
25.11.19 | Novartis Neutral | Credit Suisse Group | |
25.11.19 | Novartis Neutral | UBS AG | |
25.11.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
25.11.19 | Novartis buy | Jefferies & Company Inc. | |
18.11.19 | Novartis Underweight | JP Morgan Chase & Co. | |
31.10.19 | Novartis Hold | Deutsche Bank AG | |
30.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
25.10.19 | Novartis Underweight | Barclays Capital | |
24.10.19 | Novartis Neutral | UBS AG | |
24.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
23.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
23.10.19 | Novartis Neutral | Credit Suisse Group | |
23.10.19 | Novartis Underweight | Barclays Capital | |
23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
22.10.19 | Novartis buy | Merrill Lynch & Co., Inc. |
Werbung
Werbung